Literature DB >> 6093497

Necrotizing sarcoid granulomatosis with suppurative features.

D B Rolfes, M A Weiss, M A Sanders.   

Abstract

Necrotizing sarcoid granulomatosis has become a well-defined entity within the spectrum of disorders classified as pulmonary granulomatosis with angiitis. It is characterized clinically by disease generally restricted to the chest, steroid sensitivity, and a good prognosis. Pathologically, confluent granulomas, vasculitis, and bland necrosis are seen. The authors report a patient initially presenting with the typical clinical and pathologic features of necrotizing sarcoid granulomatosis who, on subsequent recurrence, demonstrated a suppurative character to the necrosis. This feature has not been reported previously, and its recognition will allow more cases to be diagnosed correctly. Serum angiotensin converting enzyme (ACE) was not elevated, and ACE could not be demonstrated in tissue from the lung biopsy obtained during recurrence of disease. This further suggests significant differences between this entity and sarcoid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093497     DOI: 10.1093/ajcp/82.5.602

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Solitary cavernous sinus neurosarcoidosis mimicking neurosyphilis.

Authors:  Dong Ha Kim; Won Ho Cho; Kyu Sup Cho; Seong Heon Cha
Journal:  J Korean Neurosurg Soc       Date:  2014-01-31

2.  Necrotising sarcoid granulomatosis. A rare granulomatous disease.

Authors:  Martina Doubková; Jitka Hausnerová; Ondřej Výška; Svatopluk Richter; Zdeněk Merta
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 3.  Pulmonary hypertension associated with sarcoidosis.

Authors:  Robert P Baughman
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 4.  Necrotizing sarcoid granulomatosis with hemoptysis: a case report and literature review.

Authors:  Haidong Huang; Chen Li; Chong Bai; Qiang Li; Weiqiang Zheng; Zhi Zhu; Paul Zarogoulidis; Konstantinos Zarogoulidis; Andreas Gschwendtner; Wolfgang Hohenforst-Schmidt; Michael Simoff
Journal:  Diagn Pathol       Date:  2013-05-13       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.